Scientists at the Massachusetts Institute of Technology have harnessed artificial intelligence to design two innovative antibiotics capable of combating superbugs such as MRSA. This breakthrough could usher in a new
All posts tagged in drug discovery
3Articles
In a significant strategic pivot, artificial intelligence drug discovery company BenevolentAI is contemplating a return to the London markets by 2026, following its planned delisting from Euronext Amsterdam. The company’s
In a world where numerous industries are reevaluating the transformative potential of artificial intelligence (AI), the pharmaceutical sector is already experiencing revolutionary changes in drug discovery. Companies like GSK and
